Medical device company ABK Biomedical raises $30m in Series C round

Halifax-based ABK Biomedical is a medical device company focused on the research, development and commercialization of imageable embolic therapies.

7 December 2022•2 mins read

[data-article-body-skeleton]{display:none!important}

JavaScript is required to read this article. Please enable it in your browser and reload the page.